Drugs, money and society (Part II).
Pharmacoeconomics started as marketing but has developed into a valuable tool in the fuller assessment of drug therapies. Its principles are now widely accepted, and many countries have government-funded agencies with responsibility for its application, most notably the National Institute for Health and Clinical Excellence in England. Many clinical pharmacologists are active in this area, and the discipline itself is part of the clinical pharmacology trainees' curriculum. Further developments will include value-based pricing and its use in cost sharing arrangements between health service and manufacturers.
Walley
Tom
T
Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK. twalley@liv.ac.uk
D016527:Drug Costs; D017850:Economics, Pharmaceutical; D006077:Government Agencies / Q000191:economics*; D006801:Humans; D009313:National Health Programs / Q000191:economics*; D017410:Practice Guidelines as Topic; D006113:United Kingdom